Lanib 4 MG (Lenvatinib) Capsules
Introduction of Lanib 4 MG: In the ever-evolving landscape of oncology, Drug International Ltd. introduces Lanib 4 Capsule, featuring Lenvatinib, a beacon of hope in the journey against various malignancies. Facilitated by Onco Solution, a global leader in medicine supply and oncology information, Lanib 4 signifies a significant stride forward in the comprehensive management of […]
Lorlanib 100 mg (Lorlatinib) Tablets
Introduction: In the ever-evolving landscape of oncology, Drug International Ltd. proudly presents Lorlanib 100 mg, featuring Lorlatinib INN, a groundbreaking medication that stands as a vanguard in the relentless pursuit of precision in cancer treatment. Facilitated by Onco Solution, a global leader in medicine supply and oncology information, Lorlanib 100 embodies a significant stride forward […]
Triliptin 100 mg (Trilagliptin) Tablets
Introduction: In the dynamic landscape of cancer care, where each breakthrough shapes the future, Drug International Ltd. introduces Triliptin 100 mg. This innovative medication, featuring Trilagliptin, places a spotlight on metabolic well-being, often overlooked in cancer treatment. Supported by Onco Solution, a global leader in medicine supply and information dissemination, Triliptin 100 mg emerges as […]
Pazonib 200 MG (Pazopanib) Tablets
Introduction: In the vast expanse of oncology, where hope intertwines with healing, Drug International Ltd. unveils Pazonib 200 , a beacon of therapeutic optimism featuring Pazopanib. Collaborating with Onco Solution, a global leader in oncology medicine supply and information provision, Pazonib 200 emerges as a stalwart in the fight against cancer. This narrative aims to […]
Cerinib 150 MG (Ceritinib) Capsules
Introduction of Cerinib 150 MG In the expansive landscape of oncology, where precision and innovation intertwine, Drug International Ltd. unveils Cerinib 150 , a groundbreaking therapeutic featuring the potent Ceritinib. In collaboration with Onco Solution, a global leader in oncology medicine supply and information dissemination, Cerinib 150 emerges as a beacon of hope in the […]
Latinib 250 MG (Lapatinib) Tablets
Introduction: In the dynamic field of oncology, where breakthroughs redefine treatment paradigms, Drug International Ltd. introduces Latinib 250 mg, featuring the potent Lapatinib. Positioned as a cornerstone in the therapeutic arsenal against specific cancer types, Latinib 250 represents a beacon of hope for patients worldwide. Through a strategic partnership with Onco Solution, a global leader […]
Sutinib 50 MG (Sunitinib) Capsules
Introduction to Sutinib 50 MG (Sunitinib) Capsules: Sutinib 50 , expertly developed by Beacon Pharmaceuticals Ltd. and distributed by Onco Solution, is a potent cancer treatment used to manage various malignancies. Sunitinib, the active component, is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that disrupts cancer cell growth and proliferation. Description: Sutinib 50 MG (Sunitinib) […]